SGMS2 and cancer: Previously, we found that malignant drug-resistant leukemia cells maintained low levels of ceramides via enhancing SM synthesis by SM synthase (SMS) and GC synthesis by GC synthase (GCS) to prevent ceramide-mediated cell death induced by anti-cancer drugs [4].